:

Homeland Security

NIAID Issues BAA for Bio-Defense Vaccine Enhancement

DDN

Wednesday, October 3rd, 2007

SHARE:

The National Institute of Allergy and Infectious Diseases (NIAID), with funding provided in whole or in part by the Biomedical Advanced Research and Development Agency, plans to fund organizations with demonstrated vaccine product development experience to produce a vaccine candidate either for a NIAID Category A or B Priority Pathogen or a candidate third generation anthrax vaccine. Sol. No. BAA-NIH-BARDA-NIAID-DMID-AI2007007. Respond by Jan. 22, 2008. Contact: Jordan Pulaski, contract specialist, 301-451-480-4675, jpulaski@niaid.nih.gov.

Congress

Senior GOP HASC Members Wittman, Turner Ousted Amid Dems’ Blue Wave

Two senior Republicans on the House Armed Services Committee, including a potential frontrunner for the panel’s top GOP role, have officially lost their reelection bids. Reps. Rob Wittman (R-Va.) and […]

Congress

Dems’ Big Night Set To Reshape Top Defense Committee Spots, As Key GOP’ers Knocked Off

Democrats’ sweeping victories in Tuesday’s midterms, taking back control of the House and Senate, are set to reshape key spots atop defense committees, to include House Armed Services panels and […]

Congress

Key Defense Committee Members Face Tight Midterm Races, Including HASC GOP’ers In Virginia

As the mid-term elections near with polls showing an increasing likelihood of a switch in majority control in the House and potentially the Senate, three Virginia Republicans on the House […]

‘Theoretical Potential’ to Achieve 1,509 Combat-Coded Fighters by 2035, USAF Says

In the latest U.S. Air Force fighter force structure report submitted to Congress, the service speaks of a “theoretical potential” to achieve a goal of 1,509 combat-coded fighters in the […]